PARP1 and acute myeloid leukemia: Thirdly, given thecorrelation between the expression levels of PARP1 andLIG3 with formation of translocations and the possibleoccurrence of these chromosomal aberrations betweendiagnosis and the relapsing stage, we suggest measuringthese two markers to predict the translocation formationand possibly to introduce them as novel therapeutictargets to prevent the relapsing phase in AML.